The Boston University School of Medicine is one of the graduate schools of Boston University. Founded in 1848, the medical school was the first institution in the world to formally educate female physicians. Originally known as the New England Female Medical College, it was subsequently renamed BUSM in 1873.

During the past decade, Boston University School Of Medicine conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 32 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 15 clinical trials were completed. i.e. 107.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston University School Of Medicine" #1 sponsor was "Boston University" with 20 trials, followed by "Actelion" with 10 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials sponsored, "University of Pennsylvania" with 8 trials sponsored and "National Institute on Aging (NIA)" with 8 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston University School Of Medicine" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 12 trials as a collaborator, "National Institute on Aging (NIA)" with 8 trials as a collaborator, "Office of Rare Diseases (ORD)" with 8 trials as a collaborator, "Rare Diseases Clinical Research Network" with 6 trials as a collaborator and "Inner-City Asthma Consortium" with 5 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 86 trials.

According to Clinical.Site data, the most researched conditions in "Boston University School Of Medicine" are "Pulmonary Hypertension" (11 trials), "Pulmonary Arterial Hypertension" (10 trials), "Alzheimer's Disease" (9 trials), "Asthma" (9 trials) and "Alzheimer Disease" (6 trials). Many other conditions were trialed in "Boston University School Of Medicine" in a lesser frequency.

Most popular intervention types in "Boston University School Of Medicine" are "Drug" (89 trials), "Other" (15 trials), "Behavioral" (10 trials), "Biological" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Laboratory Biomarker Analysis" (5 trials), "placebo" (4 trials), "Bosentan" (3 trials) and "Eplontersen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Boston University School Of Medicine" are 133 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 23 active trials in "Boston University School Of Medicine". 1 are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 89 completed trials in Boston University School Of Medicine, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Boston University School Of Medicine, 10 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 19 trials that are defined as “Not Applicable".